Albemarle (NYSE:ALB) Posts Earnings Results, Beats Estimates By $0.05 EPS

Albemarle (NYSE:ALB) issued its quarterly earnings results on Wednesday. The specialty chemicals company reported $2.58 EPS for the quarter, beating the consensus estimate of $2.53 by $0.05, FiscalAI reports. Albemarle had a net margin of 10.40% and a return on equity of 15.23%. The company had revenue of $1.55 billion for the quarter, compared to the consensus estimate of $1.52 billion. During the same period in the prior year, the firm posted ($0.19) EPS. The firm’s revenue was up 18.8% compared to the same quarter last year.

Albemarle Stock Up 0.7%

Shares of NYSE ALB traded up $0.66 during midday trading on Friday, reaching $99.03. 2,443,486 shares of the company’s stock traded hands, compared to its average volume of 2,471,948. The company has a quick ratio of 1.35, a current ratio of 2.09 and a debt-to-equity ratio of 0.22. The company has a market cap of $11.69 billion, a price-to-earnings ratio of 23.92, a P/E/G ratio of 0.57 and a beta of 1.34. The stock’s 50 day simple moving average is $108.33 and its 200-day simple moving average is $148.24. Albemarle has a one year low of $89.77 and a one year high of $221.00.

Albemarle Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, January 4th. Stockholders of record on Friday, December 18th will be given a $0.41 dividend. This represents a $1.64 annualized dividend and a dividend yield of 1.7%. The ex-dividend date of this dividend is Friday, December 18th. Albemarle’s dividend payout ratio is presently 39.61%.

Albemarle News Roundup

Here are the key news stories impacting Albemarle this week:

• Positive Sentiment: Albemarle reported third-quarter adjusted earnings of $2.58 per share, ahead of estimates, on $1.55 billion in revenue—also above forecasts and up 18.8% year over year. Higher lithium pricing, strong demand, cost reductions and improved Specialties profits supported the results. Albemarle Q3 Earnings Call Highlights Cost Discipline and Lithium Demand
• Positive Sentiment: Scotiabank maintained its “Sector Outperform” rating and $190 price target, estimating EPS of $11.64 for FY2026 and $14.15 for FY2027—above the cited current-year consensus estimate. Albemarle analyst coverage
• Positive Sentiment: Truist reaffirmed its “buy” rating, though it lowered its price target to $170 from $185. Truist rating information
• Neutral Sentiment: RBC cut its target to $119 from $129 but retained an “outperform” rating, reflecting a more cautious valuation alongside continued optimism about the shares. RBC rating information
• Negative Sentiment: Barclays lowered its target to $95 from $109 and kept an “equal weight” rating, pointing to a less favorable near-term risk-reward view. Lithium prices remain volatile, a potential source of uncertainty for earnings. Barclays rating information

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the company. BMO Capital Markets reiterated an “outperform” rating and issued a $175.00 price target on shares of Albemarle in a report on Tuesday, October 6th. Royal Bank Of Canada decreased their target price on Albemarle from $129.00 to $119.00 and set an “outperform” rating for the company in a research report on Friday. UBS Group decreased their target price on Albemarle from $175.00 to $150.00 and set a “buy” rating for the company in a research report on Monday, October 5th. Zacks Research lowered shares of Albemarle from a “hold” rating to a “strong sell” rating in a research note on Friday, October 9th. Finally, Morgan Stanley restated a “reduce” rating and issued a $161.00 price target on shares of Albemarle in a report on Monday, August 10th. Fifteen analysts have rated the stock with a Buy rating, seven have issued a Hold rating and three have given a Sell rating to the company. According to MarketBeat, the company has an average rating of “Hold” and an average target price of $177.64.

About Albemarle

Albemarle Corporation (NYSE: ALB) is a global specialty chemicals company headquartered in Charlotte, North Carolina. The company develops, manufactures, and markets engineered chemicals used in energy storage, transportation, refining, pharmaceuticals, agriculture, consumer products, and other industrial applications.

Albemarle is one of the world’s major producers of lithium and supplies lithium compounds, including lithium carbonate and lithium hydroxide, for use in rechargeable batteries for electric vehicles, portable electronics, and grid energy-storage systems.